Annual Accounts Payable
$1.81 M
-$1.05 M-36.68%
31 December 2023
Summary:
Trevi Therapeutics annual accounts payable is currently $1.81 million, with the most recent change of -$1.05 million (-36.68%) on 31 December 2023. During the last 3 years, it has fallen by -$207.00 thousand (-10.27%). TRVI annual accounts payable is now -36.68% below its all-time high of $2.86 million, reached on 31 December 2022.TRVI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.61 M
+$103.00 K+6.82%
30 September 2024
Summary:
Trevi Therapeutics quarterly accounts payable is currently $1.61 million, with the most recent change of +$103.00 thousand (+6.82%) on 30 September 2024. Over the past year, it has increased by +$358.00 thousand (+28.50%). TRVI quarterly accounts payable is now -59.01% below its all-time high of $3.94 million, reached on 30 June 2022.TRVI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRVI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.7% | +28.5% |
| 3 y3 years | -10.3% | -27.7% |
| 5 y5 years | +200.0% | +230.1% |
TRVI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.7% | at low | -59.0% | +28.5% |
| 5 y | 5 years | -36.7% | +200.0% | -59.0% | +230.1% |
| alltime | all time | -36.7% | +236.9% | -59.0% | +230.1% |
Trevi Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.61 M(+6.8%) |
| June 2024 | - | $1.51 M(-28.5%) |
| Mar 2024 | - | $2.11 M(+16.7%) |
| Dec 2023 | $1.81 M(-36.7%) | $1.81 M(+44.0%) |
| Sept 2023 | - | $1.26 M(-7.1%) |
| June 2023 | - | $1.35 M(-31.8%) |
| Mar 2023 | - | $1.98 M(-30.6%) |
| Dec 2022 | $2.86 M(+0.3%) | $2.86 M(+22.5%) |
| Sept 2022 | - | $2.33 M(-40.8%) |
| June 2022 | - | $3.94 M(+126.6%) |
| Mar 2022 | - | $1.74 M(-39.0%) |
| Dec 2021 | $2.85 M | $2.85 M(+27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $2.23 M(-36.0%) |
| June 2021 | - | $3.49 M(+335.5%) |
| Mar 2021 | - | $801.00 K(-60.3%) |
| Dec 2020 | $2.02 M(+26.1%) | $2.02 M(+60.3%) |
| Sept 2020 | - | $1.26 M(-60.2%) |
| June 2020 | - | $3.16 M(+44.1%) |
| Mar 2020 | - | $2.19 M(+37.1%) |
| Dec 2019 | $1.60 M(+165.2%) | $1.60 M(+227.0%) |
| Sept 2019 | - | $489.00 K(-81.6%) |
| June 2019 | - | $2.66 M(+434.7%) |
| Mar 2019 | - | $498.00 K(-17.4%) |
| Dec 2018 | $603.00 K(+12.3%) | $603.00 K |
| Dec 2017 | $537.00 K | - |
FAQ
- What is Trevi Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Trevi Therapeutics?
- What is Trevi Therapeutics annual accounts payable year-on-year change?
- What is Trevi Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly accounts payable year-on-year change?
What is Trevi Therapeutics annual accounts payable?
The current annual accounts payable of TRVI is $1.81 M
What is the all time high annual accounts payable for Trevi Therapeutics?
Trevi Therapeutics all-time high annual accounts payable is $2.86 M
What is Trevi Therapeutics annual accounts payable year-on-year change?
Over the past year, TRVI annual accounts payable has changed by -$1.05 M (-36.68%)
What is Trevi Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TRVI is $1.61 M
What is the all time high quarterly accounts payable for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly accounts payable is $3.94 M
What is Trevi Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TRVI quarterly accounts payable has changed by +$358.00 K (+28.50%)